# Efficacy of MEMORMAX in Subjects With MCI

> **NCT03581929** · NA · COMPLETED · sponsor: **Aboca Spa Societa' Agricola** · enrollment: 50 (actual)

## Conditions studied

- Mild Cognitive Impairment

## Interventions

- **DIETARY_SUPPLEMENT:** Memormax
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03581929
- **Lead sponsor:** Aboca Spa Societa' Agricola
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-20
- **Primary completion:** 2019-12-19
- **Final completion:** 2019-12-19
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2020-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03581929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03581929, "Efficacy of MEMORMAX in Subjects With MCI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03581929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*